|
⚲
|
| Keyboard |
| Tyndall Mark Anthony
✚
|
|
|---|---|
| CIK # | 0001944622 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001944622] | |
| 4 | [0001944622] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tyndall Mark Anthony | |
| Keenova Therapeutics PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
|
2026-02-25 | Grant | 51,794 | $0.00 | |
|
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
|
2026-01-01 | Option exercise | 6,576 | $0.00 | |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2026-01-01 | Tax withheld | 2,107 | ||
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2026-01-01 | Option exercise | 6,576 | ||
|
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
|
2025-07-31 | Grant | 32,828 | $0.00 | |
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-01-01 | Tax withheld | 1,772 | ||
|
Keenova Therapeutics PLC NONE
Ordinary Shares
|
2025-01-01 | Option exercise | 5,470 | ||
|
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
|
2025-01-01 | Option exercise | 5,470 | $0.00 | |
|
Keenova Therapeutics PLC NONE
Restricted Stock Units · derivative
|
2024-02-02 | Grant | 16,413 | $0.00 | |
|
Keenova Therapeutics PLC MNKTQ
Ordinary Shares
|
2023-11-14 | Disposed to issuer | 63,802 | $0.00 | |
|
Keenova Therapeutics PLC MNK
Ordinary Shares
|
2023-08-17 | Tax withheld | 11,289 | $0.69 | 7,789 |
|
Keenova Therapeutics PLC MNK
Restricted Stock Units · derivative
|
2023-06-30 | Disposed to issuer | 114,402 | $0.00 | |
|
Keenova Therapeutics PLC MNK
Restricted Stock Units · derivative
|
2023-04-03 | Grant | 114,402 | $0.00 | |
|
Keenova Therapeutics PLC MNK
Ordinary Shares
|
2022-12-14 | Grant | 75,091 | $0.00 |